Christopher Bowden Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Bowden.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Christopher Bowden for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 3,333 | 0 | 6,667 | |
| Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 48.66 | 1,596 | 77,661 | 5,318 | 6.9 K to 5.3 K (-23.08 %) |
| Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 3,333 | 0 | 6,914 | 3.6 K to 6.9 K (+93.07 %) |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 0.00 | 2,750 | 0 | 2,750 | |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 51.51 | 45,000 | 2,317,950 | 45,000 | |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Payment of Exercise | F | 52.01 | 819 | 42,596 | 3,581 | 4.4 K to 3.6 K (-18.61 %) |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 0.00 | 2,750 | 0 | 4,400 | 1.7 K to 4.4 K (+166.67 %) |
| Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 621 | 21,834 | 26,406 | |
| Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.02 | 621 | 31,063 | 1,650 | 2.3 K to 1.7 K (-27.34 %) |
| Feb 13 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 621 | 21,834 | 2,271 | 1.7 K to 2.3 K (+37.64 %) |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 35,447 | 1,246,317 | 27,027 | |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 8,526 | 299,774 | 62,474 | |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.10 | 35,447 | 1,776,026 | 1,650 | 37.1 K to 1.7 K (-95.55 %) |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 35,447 | 1,246,317 | 37,097 | 1.7 K to 37.1 K (+2,148.30 %) |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 50.03 | 14,191 | 709,963 | 1,650 | 15.8 K to 1.7 K (-89.58 %) |
| Feb 06 2020 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 8,526 | 299,774 | 15,841 | 7.3 K to 15.8 K (+116.56 %) |